Pre-Market Movers (AudioCodes, Allot, Nokia, Wendy's, Dreyfus, Zynga, Novo Nordisk, ARM Holdings, Elan Corporation)

  on

AudioCodes Ltd, Allot Communications Ltd, Nokia Corporation, The Wendy's Company, Dreyfus High Yield Strategies Fund, Zynga Inc, Novo Nordisk A/S, ARM Holdings Plc and Elan Corporation Plc are among the companies whose shares are moving in the pre-market trading Monday.

AudioCodes Ltd (NASDAQ:AUDC) advanced 7.74 percent to $4.73 in pre-market trading. The company announced Monday that it has been awarded an approximately $6 million project from a Tier 1 operator, which will be implemented in phases over several years.

Allot Communications Ltd (NASDAQ:ALLT) gained 4.10 percent to $14.47 in pre-market trading. The company shares have a 52-week low of $5.75, a 52-week high of $35.79 and a market capitalization of $1.04 billion.

Nokia Corporation (NYSE:NOK) stock rose 2.46 percent to $4.17 in pre-market trading. The company shares have a 52-week trading range of $1.63-$5.87 and a market capitalization of $15.24 billion.

The Wendy's Company (NASDAQ:WEN) stock advanced 3.78 percent to $5.21 in pre-market trading. The company stock has a 52-week trading range of $4.09-$5.33 and a market capitalization of $1.96 billion.

Dreyfus High Yield Strategies Fund (NYSE:DHF) stock rallied 2.33 percent to $4.40 in pre-market trading. The company shares have a 52-week trading range of $3.75-$4.70 and a market capitalization of $309.47 million.

Zynga Inc (NASDAQ:ZNGA) stock climbed 2.04 percent to $3.50 in pre-market trading. Zynga reported fourth-quarter earnings and sales late Tuesday, revealing that the company earned 1 cent per share, or $6.9 million, on sales of $311 million last quarter. Analysts polled by Thomson Reuters expected a loss of 3 cents per share and $212 million in revenue.

Novo Nordisk A/S (NYSE:NVO) stock declined 12.58 percent to $168.10 in pre-market trading. The company shares slumped after it said Sunday that FDA has declined to approve its 'new generation' insulin products - Tresiba and Ryzodeg. The Danish pharmaceutical company said FDA has requested additional cardiovascular data from a dedicated cardiovascular outcome trial, which the company said it does not expect to provide during 2013.

ARM Holdings Plc (NASDAQ:ARMH) shares dropped 3.01 percent to $42.21 in pre-market trading The company shares have a 52-week low of $21.64 and a 52-week high of $44.19 and a market capitalization of $20.03 billion. 

Elan Corporation Plc (NYSE:ELN) fell 1.43 percent to $9.68 in pre-market trading. The company shares have a 52-week low of $9.37 and a 52-week high of $15.27 and a market capitalization of $50.83 billion. 

Join the Discussion